Testing and clinical implications for non‐V600 <i>BRAF</i> mutations in metastatic <i>NRAS</i> ^<i>mt</i> melanoma

Georg Richtig, Ariane Aigelsreiter, Karl Kashofer et al.|British Journal of Dermatology|2016

Cited by 3